1. Home
  2. Advocacy
  3. Laboratory Oversight and Regulation
  4. Laboratory-Developed Test Oversight

Laboratory-Developed Test Oversight


CAP Advocacy promotes a favorable, effective regulatory environment through its engagement with the Congress, Food and Drug Administration (FDA), Centers for Medicare & Medicaid Services (CMS), and other industry groups for a sensible public-private oversight to ensure the quality and accuracy of laboratory-developed tests (LDTs).

With Congress pursuing the enactment of an LDT oversight plan, the CAP advocates to protect patients and to provide access to safe diagnostic tests with a framework that is the least burdensome for laboratories. Any extraneous provisions included in legislation interfere with the goals of ensuring access and quality tests for patients.

Additional Information